Registered entities
FRONTIER MEDICINES CORPORATION
Reg. No. 824849258United States
Innovation
22 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 299 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 5 |
Social engagement
Social engagement: 21.5K social following, 9 posts in the last 12 months — around the industry typical range.
Investor mix
13 investors on record; lead investors include Deerfield, Droia, RA Capital Management, Woodline Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 38% |
| Accelerator & incubator | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 6 | 46% |
Hiring activity
Hires periodically
3 roles tracked across 3 of the last 12 months
15 May 2026 · Director/Sr. Director/Executive Director, Clinical Operations · Boston
10 Mar 2026 · Director Clinical Operations · Boston
25 Feb 2026 · Director, Clinical Operations · Boston
23 May 2025 · Director, Head of Research Informatics · Boston
Based on job postings tracked across public sources.
Recent activity
20 Apr 2026
Event
AACR26
17 Apr 2026
Event
American Association for Cancer Research Annual Meeting
14 Apr 2026
Event
Drug Discovery Chemistry Conference 2026